Bell Potter Securities

Willed is an Australian online estate planning platform designed to simplify the process of end-of-life planning. It provides users with the tools to create legally valid wills from the comfort of their own homes, at their own pace, and at a lower cost than traditional methods. The platform aims to make it easier for individuals to organize their affairs, ensuring that their spouses, children, and assets are adequately protected after their passing. By offering an accessible and user-friendly approach to will-writing, Willed addresses a critical need in estate planning for individuals looking to secure their legacies.

Credit Clear is a seamless mobile communication, billing and payment solution.Credit Clear can also replace traditional billing systems with a digital and actionable invoices. Credit clear's disruptive technology houses a machine learning engine, which transforms the collections landscape by profiling customers to provide intelligent insights, including automating the optimum contact time to request payments from customers and the curation of tailored messages.

Agersens Pty Ltd., a technology company, develops an animal collar and phone application named eShepherd for beef and dairy farmers to automate the movement and control of their livestock. The company’s customers include largescale beef producer, beef farmers, dairy farmers, natural resource managers, and researchers. Agersens Pty Ltd. was founded in 2014 and is headquartered in Camberwell, Australia.

Osprey Medical, Inc., incorporated in 2005 and based in Minnetonka, Minnesota, is a medical device company specializing in technologies aimed at reducing the risks associated with contrast agents used in angiographic imaging procedures. The company's primary focus is on protecting patients from Contrast Induced Nephropathy (CIN), a potential complication from X-ray dye used in cardiovascular and peripheral interventions. Osprey Medical offers several products, including the AVERT and DyeVert systems, designed to minimize the amount of contrast material administered during these procedures. The technology behind the CINCOR™ System, which is a key component of its product line, was initially developed at the Baker Heart and Diabetes Institute in Australia. Through its innovative solutions, Osprey Medical aims to enhance patient safety and improve outcomes in diagnostic imaging.